260 related articles for article (PubMed ID: 18302746)
21. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.
Khattak AA; Venkatesan M; Khatoon L; Ouattara A; Kenefic LJ; Nadeem MF; Nighat F; Malik SA; Plowe CV
Malar J; 2013 Sep; 12():310. PubMed ID: 24007534
[TBL] [Abstract][Full Text] [Related]
22. Genetic Polymorphisms in Plasmodium vivax Dihydrofolate Reductase and Dihydropteroate Synthase in Isolates from the Philippines, Bangladesh, and Nepal.
Thongdee P; Kuesap J; Rungsihirunrat K; Dumre SP; Espino E; Noedl H; Na-Bangchang K
Korean J Parasitol; 2015 Apr; 53(2):227-32. PubMed ID: 25925184
[TBL] [Abstract][Full Text] [Related]
23. Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapy.
Gresty KJ; Gray KA; Bobogare A; Wini L; Taleo G; Hii J; Cheng Q; Waters NC
Malar J; 2014 Oct; 13():402. PubMed ID: 25311473
[TBL] [Abstract][Full Text] [Related]
24. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
Marfurt J; de Monbrison F; Brega S; Barbollat L; Müller I; Sie A; Goroti M; Reeder JC; Beck HP; Picot S; Genton B
J Infect Dis; 2008 Aug; 198(3):409-17. PubMed ID: 18582193
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium vivax in the Democratic Republic of East Timor: Parasite prevalence and antifolate resistance-associated mutations.
de Almeida A; Rosário VE; Henriques G; Arez AP; Cravo P
Acta Trop; 2010 Sep; 115(3):288-92. PubMed ID: 20412783
[TBL] [Abstract][Full Text] [Related]
26. Amino acid mutation in
Maghsoodloorad S; Hosseinzadeh N; Haghighi A; Solgi R; Yusuf MA; Hatam G
J Vector Borne Dis; 2019; 56(2):170-173. PubMed ID: 31397394
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of polymorphisms in antifolate drug resistance molecular marker genes pvdhfr and pvdhps in clinical isolates of Plasmodium vivax from Kolkata, India.
Ganguly S; Saha P; Chatterjee M; Maji AK
Antimicrob Agents Chemother; 2014; 58(1):196-200. PubMed ID: 24145518
[TBL] [Abstract][Full Text] [Related]
28. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
[TBL] [Abstract][Full Text] [Related]
29. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Auliff A; Wilson DW; Russell B; Gao Q; Chen N; Anh le N; Maguire J; Bell D; O'Neil MT; Cheng Q
Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682
[TBL] [Abstract][Full Text] [Related]
30. Presence of novel triple mutations in the pvdhfr from Plasmodium vivax in Mangaluru city area in the southwestern coastal region of India.
Joy S; Ghosh SK; Achur RN; Gowda DC; Surolia N
Malar J; 2018 Apr; 17(1):167. PubMed ID: 29661235
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of mutations in the antifolates resistance-associated genes (dhfr and dhps) in Plasmodium vivax parasites from Eastern and Central Sudan.
Pirahmadi S; Talha BA; Nour BY; Zakeri S
Infect Genet Evol; 2014 Aug; 26():153-9. PubMed ID: 24861816
[TBL] [Abstract][Full Text] [Related]
32. Characterization of drug resistance genes in Indian Plasmodium falciparum and Plasmodium vivax field isolates.
Narang G; Jakhan J; Tamang S; Yadav K; Singh V
Acta Trop; 2024 Jul; 255():107218. PubMed ID: 38636585
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries.
Lu F; Lim CS; Nam DH; Kim K; Lin K; Kim TS; Lee HW; Chen JH; Wang Y; Sattabongkot J; Han ET
Am J Trop Med Hyg; 2010 Sep; 83(3):474-9. PubMed ID: 20810806
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
[TBL] [Abstract][Full Text] [Related]
35. Monitoring the efficacy of antimalarial medicines in India via sentinel sites: Outcomes and risk factors for treatment failure.
Mishra N; Srivastava B; Bharti RS; Rana R; Kaitholia K; Anvikar AR; Das MK; Ghosh SK; Bhatt RM; Tyagi PK; Dev V; Phookan S; Wattal SL; Sonal GS; Dhariwal AC; Valecha N
J Vector Borne Dis; 2016; 53(2):168-78. PubMed ID: 27353588
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiology of Plasmodium vivax anti-folate resistance in India.
Prajapati SK; Joshi H; Dev V; Dua VK
Malar J; 2011 Apr; 10():102. PubMed ID: 21513569
[TBL] [Abstract][Full Text] [Related]
37. A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes.
Barnadas C; Kent D; Timinao L; Iga J; Gray LR; Siba P; Mueller I; Thomas PJ; Zimmerman PA
Malar J; 2011 Sep; 10():282. PubMed ID: 21943242
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium vivax dhfr mutations among isolates from malarious areas of Iran.
Zaman J; Shahbazi A; Asgharzadeh M
Korean J Parasitol; 2011 Jun; 49(2):125-31. PubMed ID: 21738267
[TBL] [Abstract][Full Text] [Related]
39. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
Iriemenam NC; Shah M; Gatei W; van Eijk AM; Ayisi J; Kariuki S; Vanden Eng J; Owino SO; Lal AA; Omosun YO; Otieno K; Desai M; ter Kuile FO; Nahlen B; Moore J; Hamel MJ; Ouma P; Slutsker L; Shi YP
Malar J; 2012 Jul; 11():134. PubMed ID: 22540158
[TBL] [Abstract][Full Text] [Related]
40. Molecular evaluation of pvdhfr and pvmdr-1 mutants in Plasmodium vivax isolates after treatment with sulfadoxine/pyrimethamine and chloroquine in Iran during 2001-2016.
Parsaei M; Raeisi A; Spotin A; Shahbazi A; Mahami-Oskouei M; Hazratian T; Khorashad AS; Zaman J; Bazmani A; Sarafraz S
Infect Genet Evol; 2018 Oct; 64():70-75. PubMed ID: 29929007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
